18 results
8-K
EX-1.1
CGTX
Cognition Therapeutics Inc
13 Mar 24
Entry into a Material Definitive Agreement
4:07pm
by the European Union General Data Protection Regulation (“GDPR”) (EU 2016/679); (iv) any information which would qualify as “protected health
8-K
EX-10.1
CGTX
Cognition Therapeutics Inc
23 Dec 22
Entry into a Material Definitive Agreement
4:24pm
” as defined by the European Union General Data Protection Regulation (“GDPR”) (EU 2016/679); (iv) any information which would qualify as “protected health
S-3
EX-1.2
CGTX
Cognition Therapeutics Inc
23 Dec 22
Shelf registration
4:16pm
General Data Protection Regulation (“GDPR”) (EU 2016/679); (iv) any information which would qualify as “protected health information” under HIPAA; (v) any
8-K
EX-1.1
CGTX
Cognition Therapeutics Inc
14 Nov 22
Cognition Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
8:00am
” as defined by the European Union General Data Protection Regulation (“GDPR”) (EU 2016/679); (iv) any information which would qualify as “protected health
424B4
tnt5110
14 Nov 22
Prospectus supplement with pricing info
6:02am
DRS
rnlccs2iiqe0zkivb
20 Oct 22
Draft registration statement
12:00am
10-K
47hepuqr0vzofu81n0
30 Mar 22
Annual report
7:40am
10-Q
9uuwwdly0z
17 Nov 21
Quarterly report
5:15pm
424B4
1i0m oovm
12 Oct 21
Prospectus supplement with pricing info
4:11pm
S-1
8989wu3va84n
19 Jul 21
IPO registration
7:02am
DRS/A
2cf87 51kyvscick5n0
23 Jun 21
Draft registration statement (amended)
12:00am
DRS
6rh8 gwv0n
7 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next